Iovance Biotherapeutics I... (IOVA)
3.04
-0.21 (-6.46%)
At close: Apr 04, 2025, 1:54 PM
Iovance Biotherapeutics Revenue
Iovance Biotherapeutics reported an annual revenue of $164.07M, reflecting a 13698.99% growth. For the quarter ending December 31, 2024, Iovance Biotherapeutics generated $73.69M in revenue.
Revenue (ttm)
$164.07M
Revenue Growth
13698.99%
Price / Sales Ratio
13.07
Revenue / Employee
$195.79K
Employees
838
Market Cap
998.29M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 164.07M | +13698.99% |
| Dec 31, 2023 | 1.19M | +Infinity% |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |